A nanoparticle-based assay designed to measure blood levels of Clozapine in patients with schizophrenia and bipolar disorder. The assay is compatible with both point-of-care settings and traditional clinical laboratory analyzers. It enables healthcare professionals to monitor drug efficacy and optim...
Manufactured by
DiaSystem Scandinavia AB
Huskvarna, Sweden
Diasystem Scandinavia AB is a swedish diagnostic company working in the Area of clinical chemistry, Point of Care,Hematology, Drugs of Abuse, TDM, specific Proteins and Automation. Our Customers are health care centers, hospital laboratories both in the nordic countries and other parts of the world. We import analyzers and reagents for sales in the nordic and export OEM Products globally. Our speciality is our large portfolio of reagents for screening of Drug of Abuse applied on our clinical analyzer CDT 240 as a reliable and cost.effective system.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ARK Diagnostics, Inc.
United States · 3 relevant products
Biopsense Oy
Finland · 1 relevant product
Intelligenome
United States · 3 relevant products
34 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 62 closest product alternatives
ARK Diagnostics, Inc. · United States
Qualitative and semi-quantitative immunoassay for the determination of zopiclone in clinical samples. Ready-to-use liquid formulation compatible with clinical chemistry systems for therapeutic drug monitoring.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
59 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products